Your browser doesn't support javascript.
loading
Ex vivo cytosolic delivery of functional macromolecules to immune cells.
Sharei, Armon; Trifonova, Radiana; Jhunjhunwala, Siddharth; Hartoularos, George C; Eyerman, Alexandra T; Lytton-Jean, Abigail; Angin, Mathieu; Sharma, Siddhartha; Poceviciute, Roberta; Mao, Shirley; Heimann, Megan; Liu, Sophia; Talkar, Tanya; Khan, Omar F; Addo, Marylyn; von Andrian, Ulrich H; Anderson, Daniel G; Langer, Robert; Lieberman, Judy; Jensen, Klavs F.
Afiliação
  • Sharei A; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America; Department of Microbiology and Immunobiology, Harvard Medical School, Boston
  • Trifonova R; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Jhunjhunwala S; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Hartoularos GC; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Eyerman AT; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Lytton-Jean A; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Angin M; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Sharma S; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Poceviciute R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Mao S; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Heimann M; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Liu S; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Talkar T; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Khan OF; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Addo M; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • von Andrian UH; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Anderson DG; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Langer R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Lieberman J; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Jensen KF; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
PLoS One ; 10(4): e0118803, 2015.
Article em En | MEDLINE | ID: mdl-25875117

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dextranos / Sistemas de Liberação de Medicamentos / RNA Interferente Pequeno / Dispositivos Lab-On-A-Chip / Anticorpos Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dextranos / Sistemas de Liberação de Medicamentos / RNA Interferente Pequeno / Dispositivos Lab-On-A-Chip / Anticorpos Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article